The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
De novo protein design enables the precise induction of RSV-neutralizing antibodies
Open accessAbstract
TopoBuilding precision vaccines: To induce strong and targeted neutralizing antibody (nAb) responses against vaccine targets, one strategy has been to use computationally designed immunogens. However, the structural complexity of many known neutralization epitopes has posed a major challenge for the design of accurate epitope mimetics. Sesterhenn et al. created a protein design algorithm called TopoBuilder to design scaffolds for irregular and discontinuous neutralization epitopes. As a proof of principle, the authors generated epitope-focused immunogens based on the prefusion conformation of the respiratory syncytial virus (RSV) fusion protein. When these immunogens were used to vaccinate mice and nonhuman primates in RSV infection models, they generated targeted nAb responses to RSV and boosted site-specific nAb responses in heterologous prime-boost vaccination schemes. Science , this issue p. eaay5051
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“we established an in silico benchmark test (Supplementary Table 9) comprising 25 motif-scaffolding design problems addressed in six recent publications encompassing several design methodologies4,5,29,38–40”
From De novo design of protein structure and function with RFdiffusion (2023) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [9]
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [9]
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
CTFFIND4: Fast and accurate defocus estimation from electron micrographs
Rohou, A. L., & Grigorieff, N. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.08.008 · Cited by 4,759
Principles of protein-protein interactions
Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684
Linking Crystallographic Model and Data Quality
Karplus, P. A., & Diederichs, K. (2012) · Science · doi:10.1126/science.1218231 · Cited by 1,781
Sattler, M. (1999) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/s0079-6565(98)00025-9 · Cited by 1,721
The coming of age of de novo protein design
Huang, P.-S., Boyken, S. E., & Baker, D. (2016) · Nature · doi:10.1038/nature19946 · Cited by 1,478
Herrmann, T., Güntert, P., & Wüthrich, K. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00241-3 · Cited by 1,472
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Shen, Y., & Bax, A. (2013) · Journal of Biomolecular NMR · doi:10.1007/s10858-013-9741-y · Cited by 1,140
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126
Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,078
Isolating and engineering human antibodies using yeast surface display
Chao, G., Lau, W. L., Hackel, B. J., Sazinsky, S. L., Lippow, S. M., & Wittrup, K. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.94 · Cited by 913
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Spaeth, G. B., Duangchinda, T., Sakuntabhai, A., Cao‐Lormeau, V., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 907
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883
Johnson, S., Oliver, C. N., Prince, G. A., Hemming, V. G., Pfarr, D. S., Wang, S., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J. K., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514115 · Cited by 653
de la Rosa-Trevin, J. M., Quintana, A., del Caño, L., Zaldívar-Peraza, A., Foche, I., Gutiérrez, J., Gómez-Blanco, J., Burguet–Castell, J., Cuenca-Alba, J., Abrishami, V., et al. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.04.010 · Cited by 594
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
Fleishman, S. J., Whitehead, T. A., Ekiert, D. C., Dreyfus, C., Corn, J. E., Strauch, E.-M., Wilson, I. A., & Baker, D. (2011) · Science · doi:10.1126/science.1202617 · Cited by 585
Principles for designing ideal protein structures
Koga, N., Tatsumi-Koga, R., Liu, G., Xiao, R., Acton, T. B., Montelione, G. T., & Baker, D. (2012) · Nature · doi:10.1038/nature11600 · Cited by 564
Proof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555
Self-citationDe novo design of potent and selective mimics of IL-2 and IL-15
Silva, D.-A., Yu, S., Ulge, U. Y., Spangler, J. B., Jude, K. M., Labão-Almeida, C., Ali, L. R., Quijano-Rubio, A., Ruterbusch, M., Leung, I., et al. (2019) · Nature · doi:10.1038/s41586-018-0830-7 · Cited by 531
Structural basis of potent Zika–dengue virus antibody cross-neutralization
Spaeth, G. B., Dejnirattisai, W., Rouvinski, A., Vaney, M. C., Medits, I., Sharma, A., Simon‐Lorière, E., Sakuntabhai, A., Cao‐Lormeau, V., Haouz, A., et al. (2016) · Nature · doi:10.1038/nature18938 · Cited by 530
Herrmann, T., Güntert, P., & Wüthrich, K. (2002) · Journal of Biomolecular NMR · doi:10.1023/a:1021614115432 · Cited by 482
Massively parallel de novo protein design for targeted therapeutics
Chevalier, A., Silva, D.-A., Rocklin, G. J., Hicks, D. R., Vergara, R., Murapa, P., Bernard, S. M., Zhang, L., Lam, K.-H., Yao, G., et al. (2017) · Nature · doi:10.1038/nature23912 · Cited by 453 · cited 3×
“3B), an effective method to digest partially unfolded proteins (7, 38).”
BackgroundMethodHIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Jardine, J. G., Kulp, D. W., Havenar‐Daughton, C., Sarkar, A., Briney, B. S., Sok, D., Sesterhenn, F., Ereño‐Orbea, J., Kalyuzhniy, O., Deresa, I., et al. (2016) · Science · doi:10.1126/science.aad9195 · Cited by 451
Self-citationReverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & Gregorio, E. D. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 449
Marcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W., Snijder, J., Hodge, E. A., Benhaim, M. A., Ravichandran, R., Carter, L. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 444
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Ngwuta, J. O., Chen, M., Modjarrad, K., Joyce, M. G., Kanekiyo, M., Kumar, A., Yassine, H. M., Moin, S. M., Killikelly, A. M., Chuang, G., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4241 · Cited by 439
Immune history profoundly affects broadly protective B cell responses to influenza
Andrews, S. F., Huang, Y., Kaur, K., Popova, L. I., Ho, I. Y., Pauli, N. T., Henry, C., Taylor, W. M., Lim, S., Huang, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0522 · Cited by 413
Relaxation of backbone bond geometry improves protein energy landscape modeling
Conway, P., Tyka, M. D., DiMaio, F., Konerding, D. E., & Baker, D. A. (2013) · Protein Science · doi:10.1002/pro.2389 · Cited by 408
Recent progress in broadly neutralizing antibodies to HIV
Sok, D., & Burton, D. R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0235-7 · Cited by 406
A proof of concept for structure-based vaccine design targeting RSV in humans
Crank, M. C., Ruckwardt, T. J., Chen, M., Morabito, K. M., Phung, E., Costner, P. J., Holman, L. A., Hickman, S. P., Berkowitz, N. M., Gordon, I. J., et al. (2019) · Science · doi:10.1126/science.aav9033 · Cited by 333
Elicitation of structure-specific antibodies by epitope scaffolds
Ofek, G., Guenaga, F. J., Schief, W. R., Skinner, J., Baker, D., Wyatt, R., & Kwong, P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004728107 · Cited by 278
Xu, K. Y., Acharya, P., Kong, R., Cheng, C., Chuang, G., Liu, K., Louder, M. K., O'Dell, S. J., Rawi, R., Sastry, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0042-6 · Cited by 278
Self-citationCross-neutralization of four paramyxoviruses by a human monoclonal antibody
Corti, D., Bianchi, S., Zatta, F., Minola, A., Perez, L. H., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B. J., et al. (2013) · Nature · doi:10.1038/nature12442 · Cited by 277
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Lingwood, D., McTamney, P. M., Yassine, H. M., Whittle, J. R. R., Guo, X., Boyington, J. C., Wei, C., & Nabel, G. J. (2012) · Nature · doi:10.1038/nature11371 · Cited by 269
Exploring the repeat protein universe through computational protein design
Brunette, T., Parmeggiani, F., Huang, P., Bhabha, G., Ekiert, D. C., Tsutakawa, S. E., Hura, G. L., Tainer, J. A., & Baker, D. A. (2015) · Nature · doi:10.1038/nature16162 · Cited by 258
De novo design of a four-fold symmetric TIM-barrel protein with atomic-level accuracy
Huang, P., Feldmeier, K., Parmeggiani, F., Fernández‐Velasco, D. A., Höcker, B., & Baker, D. A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1966 · Cited by 257
Defining B cell immunodominance to viruses
Angeletti, D., Gibbs, J. S., Angel, M., Košík, I., Hickman, H. D., Frank, G. M., Das, S. R., Wheatley, A. K., Prabhakaran, M. S., Leggat, D. J., et al. (2017) · Nature Immunology · doi:10.1038/ni.3680 · Cited by 257
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
Briney, B. S., Sok, D., Jardine, J. G., Kulp, D. W., Skog, P. D., Menis, S., Jacak, R., Kalyuzhniy, O., de Val, N., Sesterhenn, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.005 · Cited by 255
Self-citationComputational characterization of B-cell epitopes
Rubinstein, N. D., Mayrose, I., Dan Halperin, C., Yekutieli, D., Gershoni, J. M., & Pupko, T. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.016 · Cited by 251
Gilman, M. S. A., Castellanos, C. A., Chen, M., Ngwuta, J. O., Goodwin, E. C., Moin, S. M., Más, V., Melero, J. A., Wright, P. F., Graham, B. S., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaj1879 · Cited by 238
Self-citationWest, A. P., Diskin, R., Nussenzweig, M. C., & Björkman, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208984109 · Cited by 231
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
Azoitei, M. L., Correia, B. E., Ban, Y.-E. A., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Huang, P.-S., McLellan, J. S., Kwong, P. D., et al. (2011) · Science · doi:10.1126/science.1209368 · Cited by 224
Self-citationCorreia, B. E., Ban, Y. A., Holmes, M. A., Xu, H., Ellingson, K., Kraft, Z., Carrico, C., Boni, E., Sather, D. N., Zenobia, C., et al. (2010) · Structure · doi:10.1016/j.str.2010.06.010 · Cited by 213
Self-citationIterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
Joyce, M. G., Zhang, B., Ou, L., Chen, M., Chuang, G., Druz, A., Kong, W., Lai, Y., Rundlet, E. J., Tsybovsky, Y., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3267 · Cited by 167
De novo protein design: how do we expand into the universe of possible protein structures?
Woolfson, D. N., Bartlett, G. J., Burton, A. J., Heal, J. W., Niitsu, A., Thomson, A. R., & Wood, C. W. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.05.009 · Cited by 160
A ‘periodic table’ for protein structures
Taylor, W. R. (2002) · Nature · doi:10.1038/416657a · Cited by 150
Packing of apolar side chains enables accurate design of highly stable membrane proteins
Mravic, M., Thomaston, J. L., Tucker, M. R., Solomon, P. E., Liu, L., & DeGrado, W. F. (2019) · Science · doi:10.1126/science.aav7541 · Cited by 133
What Are the Most Powerful Immunogen Design Vaccine Strategies?Preprint
Burton, D. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a030262 · Cited by 130
Procko, E., Berguig, G. Y., Shen, B. W., Song, Y., Frayo, S., Convertine, A. J., Margineantu, D., Booth, G., Correia, B. E., Cheng, Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.034 · Cited by 127
Self-citationMcLellan, J. S., Chen, M., Chang, J., Yang, Y., Kim, A., Graham, B. S., & Kwong, P. D. (2010) · Journal of Virology · doi:10.1128/jvi.01579-10 · Cited by 127
Avnir, Y., Tallarico, A. S. C., Zhu, Q. K., Bennett, A. S., Connelly, G., Sheehan, J., Sui, J., Fahmy, A., Huang, C., Cadwell, G., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004103 · Cited by 127
High-resolution design of a protein loop
Hu, X., Wang, H., Ke, H., & Kuhlman, B. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707977104 · Cited by 126
Principles for designing proteins with cavities formed by curved β sheets
Marcos, E., Basanta, B., Chidyausiku, T. M., Tang, Y., Oberdorfer, G., Liu, G., Swapna, G. V. T., Guan, R., Silva, D., Dou, J., et al. (2017) · Science · doi:10.1126/science.aah7389 · Cited by 125
Anatomy of β-Strands at Protein–Protein Interfaces
Watkins, A. M., & Arora, P. S. (2014) · ACS Chemical Biology · doi:10.1021/cb500241y · Cited by 119
Strauch, E.-M., Bernard, S. M., La, D., Bohn, A. J., Lee, P. S., Anderson, C. E., Nieusma, T., Holstein, C. A., Garcia, N. K., Hooper, K. A., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3907 · Cited by 119
West, A. P., Diskin, R., Nussenzweig, M. C., & Björkman, P. J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s2-o33 · Cited by 114
McLellan, J. S., Correia, B. E., Chen, M., Yang, Y., Graham, B. S., Schief, W. R., & Kwong, P. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.044 · Cited by 105
Self-citationRapid search for tertiary fragments reveals protein sequence–structure relationships
Zhou, J., & Grigoryan, G. (2014) · Protein Science · doi:10.1002/pro.2610 · Cited by 100
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
Neu, K. E., Henry, C., & Wilson, P. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.012 · Cited by 87
Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells
Sundling, C., Phad, G. E., Douagi, I., Navis, M., & Hedestam, G. B. K. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.09.003 · Cited by 78
Más, V., Laura, R., Olmedillas, E., Cano, O., Palomo, C., Terrón, M. C., Luque, D., Melero, J. A., & McLellan, J. S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005859 · Cited by 77
Self-citationFenton, C., Scott, L. J., & Plosker, G. L. (2004) · Pediatric Drugs · doi:10.2165/00148581-200406030-00004 · Cited by 75
Towards functional de novo designed proteins
Dawson, W., Rhys, G. G., & Woolfson, D. N. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.06.011 · Cited by 71
Finucane, M. D., Tuna, M., Lees, J. H., & Woolfson, D. N. (1999) · Biochemistry · doi:10.1021/bi990765n · Cited by 67
Tian, D., Battles, M. B., Moin, S. M., Chen, M., Modjarrad, K., Kumar, A., Kanekiyo, M., Graepel, K. W., Taher, N. M., Hotard, A. L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01858-w · Cited by 67
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
Mousa, J. J., Binshtein, E., Human, S., Fong, R. H., Alvarado, G. S., Doranz, B. J., Moore, M. L., Ohi, M. D., & Crowe, J. E. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006837 · Cited by 43
Rosetta FunFolDes – A general framework for the computational design of functional proteins
Bonet, J., Wehrle, S., Schriever, K., Yang, C., Billet, A., Sesterhenn, F., Scheck, A., Sverrisson, F., Veselková, B., Vollers, S. S., et al. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006623 · Cited by 41
Self-citationHolliday, G., Fischer, J. D., Mitchell, J. B. O., & Thornton, J. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08190.x · Cited by 39
Sesterhenn, F., Galloux, M., Vollers, S. S., Csepregi, L., Yang, C., Descamps, D., Bonet, J., Friedensohn, S., Gaínza, P., Corthésy, P., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000164 · Cited by 35
Self-citationGottstein, D., Kirchner, D. K., & Güntert, P. (2012) · Journal of Biomolecular NMR · doi:10.1007/s10858-012-9615-8 · Cited by 32
Wang, Y., Sundling, C., Wilson, R., O'Dell, S. J., Chen, Y., Dai, K., Phad, G. E., Zhu, J., Xiao, Y., Mascola, J. R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502543 · Cited by 28
Self-citationStructure-based immunogen design — leading the way to the new age of precision vaccines
Sesterhenn, F., Bonet, J., & Correia, B. E. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.06.002 · Cited by 27
Self-citationBonet, J., Segura, J., Planas-Iglesias, J., Oliva, B., & Fernández‐Fuentes, N. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu129 · Cited by 20
Self-citationZhang, R., Martinez, D. R., Nguyen, Q. N., Pollara, J., Arifin, T., Stolarchuk, C., Foulger, A., Amos, J. D., Parks, R., Himes, J. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms12131 · Cited by 16
Wang, Y., O'Dell, S. J., Turner, H. L., Chiang, C.-I., Lei, L., Guenaga, J., Wilson, R., Martinez-Murillo, P., Doria‐Rose, N. A., Ward, A. B., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00910-17 · Cited by 14
Self-citationChimeric Pneumoviridae fusion proteins as immunogens to induce cross‐neutralizing antibody responses
Olmedillas, E., Cano, O., Martínez, I., Luque, D., Terrón, M. C., McLellan, J. S., Melero, J. A., & Más, V. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708078 · Cited by 14
Self-citationBonet, J., Harteveld, Z., Sesterhenn, F., Scheck, A., & Correia, B. E. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2796-3 · Cited by 14
Self-citationLPDI-EPFL/trivalent_cocktail: RSV_trivalent_cocktail
Sesterhenn, F. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3724330 · Cited by 1
Self-citation
Cited by
Sorted by citations
Watson, J. L., Juergens, D., Bennett, N. R., Trippe, B. L., Yim, J., Eisenach, H. E., Ahern, W., Borst, A. J., Ragotte, R. J., Milles, L. F., et al. (2022) · doi:10.1101/2022.12.09.519842 · Cited by 2,369
De novo design of protein structure and function with RFdiffusion
Watson, J. L., Juergens, D., Bennett, N. R., Trippe, B. L., Yim, J., Eisenach, H. E., Ahern, W., Borst, A. J., Ragotte, R. J., Milles, L. F., et al. (2023) · Nature · doi:10.1038/s41586-023-06415-8 · Cited by 2,325
Scaffolding protein functional sites using deep learning
Wang, J., Lisanza, S., Juergens, D., Tischer, D., Watson, J. L., Castro, K. M., Ragotte, R., Saragovi, A., Milles, L. F., Baek, M., et al. (2022) · Science · doi:10.1126/science.abn2100 · Cited by 487
Self-citationBroad betacoronavirus neutralization by a stem helix–specific human antibody
Pinto, D., Sauer, M. M., Czudnochowski, N., Low, J. S., Tortorici, M. A., Housley, M. P., Noack, J., Walls, A. C., Bowen, J. E., Guarino, B., et al. (2021) · Science · doi:10.1126/science.abj3321 · Cited by 385
Antibodies to combat viral infections: development strategies and progress
Pantaleo, G., Correia, B. E., Fenwick, C. W., Joo, V., & Perez, L. H. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 298
Self-citation
Metadata
- Authors
- Sesterhenn, F., Yang, C., Bonet, J., Cramer, J. T., Wen, X., Wang, Y., Chiang, C.-I., Abriata, L. A., Kucharska, I., Castoro, G., Vollers, S. S., Galloux, M., Dheilly, E., Rosset, S., Corthésy, P., Georgeon, S., Villard, M., Richard, C.-A., Descamps, D., Delgado, T., Oricchio, E., Rameix-Welti, M.-A., Más, V., Ervin, S., Eléouët, J.-F., Riffault, S., Bates, J. T., Julien, J.-P., Li, Y., Jardetzky, T., Krey, T., & Correia, B. E.
- Affiliations
- SIB Swiss Institute of Bioinformatics (CH)
- Medizinische Hochschule Hannover (DE)
- Stanford Medicine (US)
- Institute for Bioscience and Biotechnology Research (US)
- University of Toronto (CA)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- École Polytechnique Fédérale de Lausanne (CH)
- Instituto de Salud Carlos III (ES)
- UMR1173, INSERM, Université de Versailles St. Quentin, 78180 Montigny le Bretonneux, France.
- Atrium Health Wake Forest Baptist (US)
- University of Mississippi Medical Center (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Sesterhenn, Fabian
- Yang, Che
- Bonet, Jaume
- Cramer, Johannes T.
- Correia, Bruno E.
- ORCID
- Sesterhenn, Fabian
- Yang, Che
- Bonet, Jaume
- Cramer, Johannes T.
- Wen, Xiaolin
- Wang, Yimeng
- Chiang, Chi-I
- Abriata, Luciano A.
- Kucharska, Iga
- Vollers, Sabrina S.
- Galloux, Marie
- Rosset, Stéphane
- Georgeon, Sandrine
- Villard, Mélanie
- Richard, Charles-Adrien
- Descamps, Delphyne
- Oricchio, Elisa
- Rameix-Welti, Marie-Anne
- Más, Vicente
- Ervin, Sean
- Eléouët, Jean-François
- Riffault, Sabine
- Bates, John T.
- Julien, Jean-Philippe
- Li, Yuxing
- Jardetzky, Theodore
- Krey, Thomas
- Correia, Bruno E.
- Venue
- Science
- Published
- 2020-05-15
- Volume
- 368
- Issue
- 6492
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7391827
- OpenAlex
- W3024848554
- Cited by
- 191
- References
- 85
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 30 · 2023: 26 · 2022: 35 · 2021: 44 · 2020: 17
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- RePEc: Research Papers in Economics (submittedVersion)
- HAL (submittedVersion, other-oa)
- DORA PSI (Paul Scherrer Institute) (submittedVersion)
- Funders
- European Research Council (716058)
- Swiss National Science Foundation (310030_163139)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- de novo protein design, respiratory syncytial virus, neutralizing antibodies, vaccine design, non-human primates, therapeutic antibodies
- MeSH terms
- Humans, Protein Conformation, Recombinant Fusion Proteins, Protein Engineering, Immunodominant Epitopes, Respiratory Syncytial Virus, Human, Computational Biology, Amino Acid Motifs, Respiratory Syncytial Virus Vaccines, Antibodies, Neutralizing, Single-Domain Antibodies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
